Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.

The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.

Carneiro MV, Souza FF, Teixeira AC, Figueiredo JF, Villanova MG, Secaf M, Passos AD, Ramalho LN, Carneiro FP, Zucoloto S, Candolo Martinelli AL.

Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1204-10. doi: 10.1097/MEG.0b013e32833bec1e.

PMID:
20555268
3.

Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C.

Ishizu Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.

J Gastroenterol Hepatol. 2012 Jun;27(6):1112-6. doi: 10.1111/j.1440-1746.2011.06976.x.

PMID:
22098610
4.

Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin.

Coelho-Borges S, Cheinquer H, Wolff FH, Cheinquer N, Krug L, Ashton-Prolla P.

Arq Gastroenterol. 2012 Jan-Mar;49(1):9-13.

5.

Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C.

Lebray P, Zylberberg H, Hue S, Poulet B, Carnot F, Martin S, Chretien Y, Pol S, Caillat-Zuckman S, Bréchot C, Nalpas B.

J Viral Hepat. 2004 Mar;11(2):175-82.

PMID:
14996353
6.

C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.

Shiono Y, Ikeda R, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Imaizumi Y, Yano M, Yoshioka K, Kawanaka M, Yamada G.

Intern Med. 2001 Sep;40(9):852-6.

7.

Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.

Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C; HALT-C Trial Group..

Gastroenterology. 2006 Nov;131(5):1440-51. Epub 2006 Aug 18.

PMID:
17101320
8.

Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.

Kucinskas L, Juzenas S, Sventoraityte J, Cedaviciute R, Vitkauskiene A, Kalibatas V, Kondrackiene J, Kupcinskas L.

Ann Hematol. 2012 Apr;91(4):491-5. doi: 10.1007/s00277-011-1338-5. Epub 2011 Sep 27.

PMID:
21947086
9.

Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.

Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, Siewert E, Gartung C, Lorenzen J, Bosserhoff AK, Brügmann M, Gressner AM, Matern S, Lammert F.

Liver Int. 2004 Aug;24(4):285-94.

PMID:
15287851
10.

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D.

J Hepatol. 2003 Mar;38(3):335-42.

PMID:
12586300
12.

Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.

de Diego C, Murga MJ, Martínez-Castro P.

Genet Test. 2004 Fall;8(3):263-7.

PMID:
15727249
13.

Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands.

Milman N, á Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC.

Ann Hematol. 2005 Mar;84(3):146-9. Epub 2004 Mar 23.

PMID:
15042317
14.

Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands.

Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT.

Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):147-55.

PMID:
10575540
15.

S65C and other mutations in the haemochromatosis gene in the Czech population.

Cimburová M, Půtová I, Provazníková H, Pintérová D, Horák J.

Folia Biol (Praha). 2005;51(6):172-6.

16.

[Iron as comorbid factor in chronic hepatitis C].

Erhardt A, Hauck K, Häussinger D.

Med Klin (Munich). 2003 Dec 15;98(12):685-91. Review. German.

PMID:
14685669
17.

Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.

Mah YH, Kao JH, Liu CJ, Chen CL, Chen PJ, Lai MY, Chen DS.

Liver Int. 2005 Apr;25(2):214-9.

PMID:
15780041
18.

Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population.

Lin A, Yan WH, Xu HH, Zhu M, Zhou MY.

Tissue Antigens. 2007 Sep;70(3):252-5.

PMID:
17661915
19.

Analysis of HFE gene mutations (C282Y, H63D, and S65C) in the Ecuadorian population.

Leone PE, Giménez P, Collantes JC, Paz-y-Miño C.

Ann Hematol. 2005 Feb;84(2):103-5. Epub 2004 Oct 29.

PMID:
15517265
20.

Prevalence of the C282Y, H63D, and S65C mutations of the HFE gene in 1,146 newborns from a region of Northern Spain.

Altes A, Ruiz A, Barceló MJ, Remacha AF, Puig T, Maya AJ, Castell C, Amate JM, Saz Z, Baiget M.

Genet Test. 2004 Winter;8(4):407-10.

PMID:
15684872

Supplemental Content

Support Center